Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares fell to a low of $3.88 before closing at $3.90. Intraday shares traded counted 1.09 million, which was -16.77% lower
Adaptimmune Therapeutics plc (NASDAQ:ADAP) has a beta of 2.16. The stock’s Relative Strength Index (RSI) is 28.84, with weekly volatility at 7.30% and ATR at
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Relative Strength Index (RSI) is 40.70, with weekly volatility at 3.98% and ATR at 0.28. The ADAP stock’s 52-week price range
Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares traded lower over the last trading session, losing -0.40% on 05/28/21. The shares fell to a low of $4.725 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
